49 related articles for article (PubMed ID: 16269130)
1. Exposure of protein kinase motifs that trigger binding of Hsp90 and Cdc37.
Prince T; Matts RL
Biochem Biophys Res Commun; 2005 Dec; 338(3):1447-54. PubMed ID: 16269130
[TBL] [Abstract][Full Text] [Related]
2. The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail.
Gould CM; Kannan N; Taylor SS; Newton AC
J Biol Chem; 2009 Feb; 284(8):4921-35. PubMed ID: 19091746
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 provides a platform for kinase dephosphorylation by PP5.
Jaime-Garza M; Nowotny CA; Coutandin D; Wang F; Tabios M; Agard DA
Nat Commun; 2023 Apr; 14(1):2197. PubMed ID: 37069154
[TBL] [Abstract][Full Text] [Related]
4. Structural dynamics of RAF1-HSP90-CDC37 and HSP90 complexes reveal asymmetric client interactions and key structural elements.
Finci LI; Chakrabarti M; Gulten G; Finney J; Grose C; Fox T; Yang R; Nissley DV; McCormick F; Esposito D; Balius TE; Simanshu DK
Commun Biol; 2024 Mar; 7(1):260. PubMed ID: 38431713
[TBL] [Abstract][Full Text] [Related]
5. Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System.
Bunney TD; Inglis AJ; Sanfelice D; Farrell B; Kerr CJ; Thompson GS; Masson GR; Thiyagarajan N; Svergun DI; Williams RL; Breeze AL; Katan M
Structure; 2018 Mar; 26(3):446-458.e8. PubMed ID: 29478821
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-1 inhibits the activation of IRE1 by targeting Hsp90/p-Cdc37 chaperone complex in Parkinson disease.
Zeng X; Geng W; Zhang Y; Yin J; Xu G; Yu M; Li L; Jia J
Ageing Res Rev; 2023 Sep; 90():102000. PubMed ID: 37437766
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of the Hsp90/Cdc37 Interaction in Neurodegenerative Diseases.
Gracia L; Lora G; Blair LJ; Jinwal UK
Front Neurosci; 2019; 13():1263. PubMed ID: 31824256
[TBL] [Abstract][Full Text] [Related]
8. Assembly mechanism of early Hsp90-Cdc37-kinase complexes.
Keramisanou D; Vasantha Kumar MV; Boose N; Abzalimov RR; Gelis I
Sci Adv; 2022 Mar; 8(11):eabm9294. PubMed ID: 35294247
[TBL] [Abstract][Full Text] [Related]
9. The double edge of the HSP90-CDC37 chaperone machinery: opposing determinants of kinase stability and activity.
Xu W; Neckers L
Future Oncol; 2012 Aug; 8(8):939-42. PubMed ID: 22894668
[TBL] [Abstract][Full Text] [Related]
10. Hsp90 and phosphorylation of the Slt2(Mpk1) MAP kinase activation loop are essential for catalytic, but not non-catalytic, Slt2-mediated transcription in yeast.
Millson SH; Truman AW; Piper PW
Cell Stress Chaperones; 2022 May; 27(3):295-304. PubMed ID: 35420390
[TBL] [Abstract][Full Text] [Related]
11. Chaperone-like protein DAY plays critical roles in photomorphogenesis.
Lee HS; Choi I; Jeon Y; Ahn HK; Cho H; Kim J; Kim JH; Lee JM; Lee S; Bünting J; Seo DH; Lee T; Lee DH; Lee I; Oh MH; Kim TW; Belkhadir Y; Pai HS
Nat Commun; 2021 Jul; 12(1):4194. PubMed ID: 34234144
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting of HSP70 does not induce the heat shock response and synergistically reduces cell viability in muscle invasive bladder cancer.
Prince T; Ackerman A; Cavanaugh A; Schreiter B; Juengst B; Andolino C; Danella J; Chernin M; Williams H
Oncotarget; 2018 Aug; 9(66):32702-32717. PubMed ID: 30220976
[TBL] [Abstract][Full Text] [Related]
13. Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation.
Mitra S; Ghosh B; Gayen N; Roy J; Mandal AK
J Biol Chem; 2016 Nov; 291(47):24579-24593. PubMed ID: 27703006
[TBL] [Abstract][Full Text] [Related]
14. Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ.
Sonamoto R; Kii I; Koike Y; Sumida Y; Kato-Sumida T; Okuno Y; Hosoya T; Hagiwara M
Sci Rep; 2015 Aug; 5():12728. PubMed ID: 26234946
[TBL] [Abstract][Full Text] [Related]
15. ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system.
Polier S; Samant RS; Clarke PA; Workman P; Prodromou C; Pearl LH
Nat Chem Biol; 2013 May; 9(5):307-12. PubMed ID: 23502424
[TBL] [Abstract][Full Text] [Related]
16. HSP90 at the hub of protein homeostasis: emerging mechanistic insights.
Taipale M; Jarosz DF; Lindquist S
Nat Rev Mol Cell Biol; 2010 Jul; 11(7):515-28. PubMed ID: 20531426
[TBL] [Abstract][Full Text] [Related]
17. Geldanamycin selectively targets the nascent form of ERBB3 for degradation.
Gerbin CS; Landgraf R
Cell Stress Chaperones; 2010 Sep; 15(5):529-44. PubMed ID: 20084478
[TBL] [Abstract][Full Text] [Related]
18. Targeting the oncogene and kinome chaperone CDC37.
Gray PJ; Prince T; Cheng J; Stevenson MA; Calderwood SK
Nat Rev Cancer; 2008 Jul; 8(7):491-5. PubMed ID: 18511936
[TBL] [Abstract][Full Text] [Related]
19. Expressed in the yeast Saccharomyces cerevisiae, human ERK5 is a client of the Hsp90 chaperone that complements loss of the Slt2p (Mpk1p) cell integrity stress-activated protein kinase.
Truman AW; Millson SH; Nuttall JM; King V; Mollapour M; Prodromou C; Pearl LH; Piper PW
Eukaryot Cell; 2006 Nov; 5(11):1914-24. PubMed ID: 16950928
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
